Xylem (XYL)
(Real Time Quote from BATS)
$139.25 USD
+1.76 (1.28%)
Updated Jul 22, 2024 01:12 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Xylem (XYL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$151.00 | $170.00 | $122.00 | 9.83% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Xylem comes to $151.00. The forecasts range from a low of $122.00 to a high of $170.00. The average price target represents an increase of 9.83% from the last closing price of $137.49.
Analyst Price Targets (14)
Broker Rating
Xylem currently has an average brokerage recommendation (ABR) of 1.72 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 1.72 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, 11 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 61.11% and 5.56% of all recommendations. A month ago, Strong Buy made up 61.11%, while Buy represented 5.56%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/XYL.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 11 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.72 | 1.72 | 1.72 | 1.76 | 1.76 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/4/2024 | Atlantic Equities | Richard Radbourne | Strong Buy | Strong Buy |
5/29/2024 | Argus Research Corp. | John M Eade | Not Available | Strong Buy |
5/8/2024 | Seaport Research Partners | Scott Graham | Hold | Hold |
5/3/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/3/2024 | Mizuho SecuritiesUSA | Brett Linzey | Hold | Hold |
5/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/8/2024 | Not Identified | Not Identified | Hold | Hold |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Joseph Giordano | Strong Buy | Strong Buy |
3/31/2024 | Goldman Sachs | Brian K Lee | Strong Buy | Strong Buy |
3/27/2024 | Northcoast Research | Ryan M Connors | Hold | Hold |
3/21/2024 | Robert W. Baird & Co. | Michael P Halloran | Strong Buy | Strong Buy |
3/12/2024 | Exane BNP Paribas | Andrew E Buscaglia | Not Available | Strong Buy |
1/4/2024 | Raymond James | Pavel S Molchanov | Strong Sell | Hold |
10/2/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.72 |
ABR (Last week) | 1.72 |
# of Recs in ABR | 18 |
Average Target Price | $151.00 |
LT Growth Rate | 13.30% |
Industry | Manufacturing - General Industrial |
Industry Rank by ABR | 94 of 252 |
Current Quarter EPS Est: | 1.06 |